Physician profile

Sudhir Agarwal

Cardiovascular Disease · Trinity, FL

NPI 1144215138

$6,459.30

in general payments reported to CMS, 2019-2025

34 companies · $1,519 in 2025

The $1,519 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,080.80
Education$99.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $1,282.96 2019-2025 Farxiga, Brilinta, Lokelma
Janssen Pharmaceuticals, INC $485.30 2021-2024 Xarelto
Pfizer INC. $426.13 2022-2025
Novartis Pharmaceuticals Corporation $374.70 2020-2025
Merck Sharp & Dohme LLC $340.99 2021-2025 Verquvo
Shockwave Medical, INC $335.72 2025
Amgen INC. $335.48 2020-2025 Repatha, Repatha
Boehringer Ingelheim Pharmaceuticals, INC. $317.88 2019-2025 Jardiance
Medtronic, INC. $305.74 2021-2024 Linq II, Micra, Tyrx
Boston Scientific Corporation $299.82 2019-2025 Watchman Flx, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet
Cardiva Medical, INC. $294.98 2024-2025 Optowire, Other
Actelion Pharmaceuticals US, INC. $187.95 2022-2025 Opsumit, Uptravi
Abbott Laboratories $186.86 2021-2025 Triclip
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $173.67 2019-2025 Lifevest
Bayer Healthcare Pharmaceuticals INC. $118.26 2022-2025
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Cardiovascular Systems INC. $113.46 2021-2022
Acist Medical Systems, INC. $91.63 2019
E.R. Squibb & Sons, L.L.C. $73.29 2022-2023 Eliquis
Scpharmaceuticals INC. $64.50 2023-2025
Novo Nordisk INC $62.69 2022-2025 Wegovy, Ozempic
Abiomed $61.49 2023-2025 Impella
Glaxosmithkline, LLC. $57.03 2020-2022
Lexicon Pharmaceuticals, INC. $56.31 2023-2024 Inpefa
Stimwave Technologies Incorporated $51.00 2021
Sanofi-Aventis U.S. LLC $49.59 2023
Irhythm Technologies, INC. $48.33 2023-2024 Zio Xt Patch, Zio Monitor
Opsens INC. $44.55 2022
Corcept Therapeutics $43.80 2025 Korlym
Gilead Sciences, INC. $41.58 2022-2023 Trodelvy
Esperion Therapeutics, INC. $34.33 2024-2025 Nexletol
Kiniksa Pharmaceuticals, LTD. $29.92 2021-2023 Arcalyst
Kiniksa Pharmaceuticals International, Plc $25.47 2024 Arcalyst
Vital Connect, INC $24.80 2023 Vitalpatch Rtm
Lundbeck LLC $19.09 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sudhir Agarwal

$6,459.30

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $1,519 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/279130/sudhir-agarwal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.